Extrapulmonary Sarcoidosis

ABSTRACT

Sarcoidosis can affect any organ in the body. Frequently extrapulmonary manifestations of the disease are the major cause of morbidity. Treatment of extrapulmonary sarcoidosis often requires consideration of alternative immunosuppressive agents, topical therapy, or therapy that is not specifically directed against the granulomatous inflammation of the disease. This article reviews the clinical presentation and therapy of extrapulmonary sarcoidosis.

Sarcoidosis - extrapulmonary - diagnosis - therapy

REFERENCES

• 1 ACCESS Research Group . Design of A Case Control Etiology Study of Sarcoidosis (ACCESS).  J Clin Epidemiol. 1999;  52 1173-1186
• 2 Baughman R P, Teirstein A S, Judson M A et al.. Clinical characteristics of patients in a case control study of sarcoidosis.  Am J Respir Crit Care Med. 2001;  164 1885-1889
• 3 Pietinalho A, Ohmichi M, Hirasawa M et al.. Familial sarcoidosis in Finland and Hokkaido, Japan: a comparative study.  Respir Med. 1999;  93 408-412
• 4 American Thoracic Society/European Respiratory Society . Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (RS) and the World Association of Sarcoidosis and Other Granulomatous Diseases (WASOG) adopted by the ATS Board of Directors and the ERS Executive Committee, February 1999.  Am J Respir Crit Care Med. 1999;  160 736-755
• 5 Rybicki B A, Major M, Popovich J et al.. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization.  Am J Epidemiol. 1997;  145 234-241
• 6 Rybicki B A, Iannuzzi M C, Frederick M M et al.. Familial aggregation of sarcoidosis: A Case-Control Etiologic Study of Sarcoidosis (ACCESS).  Am J Respir Crit Care Med. 2001;  164 2085-2091
• 7 Judson M A, Hirst K, Iyengar S K et al.. Comparison of sarcoidosis phenotypes among affected African-American siblings.  Chest. 2006;  130 855-862
• 8 Marshall R, Theirs B, Judson M A. Sarcoidosis. In: Freedberg IM, Eisen AZ, Wolff K, et al Fitzpatrick's Dermatology in General Medicine. 7th edition. New York, NY; Mc Graw Hill
• 9 O'Neill J H. The differential diagnosis of erythema nodosum.  Del Med J. 1991;  63 683-689
• 10 Eklund A, Rizzato G. Skin manifestations in sarcoidosis.  European Respiratory Journal Monograph. 2005;  10 150-163
• 11 Judson M A, Baughman R P. Sarcoidosis. In: Baughman RP, Du Bois RM, Lynch JP Diffuse Lung Disease: A Practical Approach. London; Arnold 2004: 109-129
• 12 Spiteri M A, Matthey F, Gordon T et al.. Lupus pernio: a clinico-radiological study of thirty-five cases.  Br J Dermatol. 1985;  112 315-322
• 13 Yanardag H, Pamuk O N, Karayel T. Cutaneous involvement in sarcoidosis: analysis of the features in 170 patients.  Respir Med. 2003;  97 978-982
• 14 Katoh N, Mihara H, Yasuno H. Cutaneous sarcoidosis successfully treated with topical tacrolimus.  Br J Dermatol. 2002;  147 154-156
• 15 Lower E E, Baughman R P. Prolonged use of methotrexate for sarcoidosis.  Arch Intern Med. 1995;  155 846-851
• 16 Siltzbach L E, Teirstein A S. Chloroquine therapy in 43 patients with intrathoracic and cutaneous sarcoidosis.  Acta Med Scand Suppl. 1964;  425 302-308
• 17 Zic J A, Horowitz D H, Arzubiaga C, King T E. Treatment of cutaneous sarcoidosis with chloroquine: review of the literature.  Arch Dermatol. 1991;  127 1034-1040
• 18 Baughman R P, Judson M A, Teirstein A S, Moller D R, Lower E E. Thalidomide for chronic sarcoidosis.  Chest. 2002;  122 227-232
• 19 Bachelez H, Senet P, Cadranel J et al.. The use of tetracyclines for the treatment of sarcoidosis.  Arch Dermatol. 2001;  137 69-73
• 20 Doty J D, Mazur J E, Judson M A. Treatment of sarcoidosis with infliximab.  Chest. 2005;  127 1064-1071
• 21 Baughman R P, Lower E E. Leflunomide for chronic sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis. 2004;  21 43-48
• 22 Benez A, Metzger S, Fierlbeck G. Treatment of subcutaneous sarcoidosis with allopurinol.  Arch Dermatol. 1999;  135 1560-1561
• 23 Georgiou S, Monastirli A, Pasmatzi E, Tsambaos D. Cutaneous sarcoidosis: complete remission after oral isotretinoin therapy.  Acta Derm Venereol. 1998;  78 457-459
• 24 Breuer K, Gutzmer R, Volker B et al.. Therapy of noninfectious granulomatous skin diseases with fumaric acid esters.  Br J Dermatol. 2005;  152 1290-1295
• 25 Karrer S, Abels C, Wimmershoff M B et al.. Successful treatment of cutaneous sarcoidosis using topical photodynamic therapy.  Arch Dermatol. 2002;  138 581-584
• 26 Ohara K, Judson M A, Baughman R P. Clinical aspects of ocular sarcoidosis.  European Respiratory Journal Monograph. 2005;  10 188-209
• 27 Bradley D A, Baughman R P, Raymond L, Kaufman A H. Ocular manifestations of sarcoidosis.  Semin Respir Crit Care Med. 2002;  23 543-548
• 28 Sartwell P E, Edwards L B. Epidemiology of sarcoidosis in the US Navy.  Am J Epidemiol. 1974;  99 250-257
• 29 Rossman M D, Thompson B, Frederick M et al.. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.  Am J Hum Genet. 2003;  73 720-735
• 30 Rothova A, Alberts C, Glasius E, Kulstra A, Buitenhuis H J, Breebaart A C. Risk factors for ocular sarcoidosis.  Doc Ophthalmol. 1989;  72 287-296
• 31 Ohara K, Okubo A, Sasaki H, Kamata K. Branch retinal vein occlusion in a child with ocular sarcoidosis.  Am J Ophthalmol. 1995;  119 806-807
• 32 Rothova A. Ocular involvement in sarcoidosis.  Br J Ophthalmol. 2000;  84 110-116
• 33 Islam S M, Tabbara K F. Causes of uveitis at the Eye Center in Saudi Arabia: a retrospective review.  Ophthalmic Epidemiol. 2002;  9 239-249
• 34 Merayo-lloves J, Power W J, Rodriquez A et al.. Secondary glaucoma in patients with uveitis.  Ophthalmologica. 1999;  213 300-304
• 35 Merrill P T, Kim J, Cox T A et al.. Uveitis in the southeastern United States.  Curr Eye Res. 1997;  16 865-874
• 36 Jabs D A, Johns C A. Ocular involvement in chronic sarcoidosis.  Am J Ophthalmol. 1986;  102 297-301
• 37 Spaide R F, Ward D I. Conjunctival biopsy in the diagnosis of sarcoidosis.  Br J Ophthalmol. 1990;  74 469-471
• 38 Khan F, Wessley Z, Chazin S R, Seriff N S. Conjunctival biopsy in sarcoidosis: a simple, safe, and specific diagnostic procedure.  Ann Ophthalmol. 1977;  9 671-676
• 39 Crick R, Hoyle C, Mather G. Conjunctival biopsy in sarcoidosis.  BMJ. 1955;  ii 1180-1181
• 40 James D G. Ocular sarcoidosis.  Am J Med. 1959;  26 331-339
• 41 Wertheim M S, Mathers W D, Suhler E B et al.. Histopathological features of conjunctival sarcoid nodules using noninvasive in vivo confocal microscopy.  Arch Ophthalmol. 2005;  123 274-276
• 42 Obenauf C D, Shaw H E, Syndor C F, Klintworth G K. Sarcoidosis and its ophthalmic manifestations.  Am J Ophthalmol. 1978;  86 648-655
• 43 Sulavik S B, Palestro C J, Spencer R P et al.. Extrapulmonary sites of radiogallium accumulation in sarcoidosis.  Clin Nucl Med. 1990;  15 876-878
• 44 Rothova A. Posterior segment involvement in sarcoidosis. In: Ohno S, Aoki K, Usui M, Uchio E Uveitis Today. Amsterdam; Elsevier 1998: 207-210
• 45 Sacher M, Lanzieri C F, Sobel L I, Som P M. Computed tomography of bilateral lacrimal gland sarcoidosis.  J Comput Assist Tomogr. 1984;  8 213-215
• 46 Mayers M. Ocular sarcoidosis.  Int Ophthalmol Clin. 1990;  30 257-263
• 47 Qazi F A, Thorne J E, Jabs D A. Scleral nodule associated with sarcoidosis.  Am J Ophthalmol. 2003;  136 752-754
• 48 Silver M R, Messner L V. Sarcoidosis and its ocular manifestations.  J Am Optom Assoc. 1994;  65 321-327
• 49 Constantino T, Digre K, Zimmerman P. Neuro-ophthalmic complications of sarcoidosis.  Semin Neurol. 2000;  20 123-137
• 50 Hamanaka T, Takei A, Takemura T, Oritsu M. Pathological study of cases with secondary open-angle glaucoma due to sarcoidosis.  Am J Ophthalmol. 2002;  134 17-26
• 51 Samson C M, Waheed N, Baltatzis S, Foster C S. Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients.  Ophthalmology. 2001;  108 1134-1139
• 52 Baughman R P, Lower E E, Bradley D A, Kaufman A H. Use of cytotoxic therapy for chronic ophthalmic sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis. 1999;  16(Suppl) 17
• 53 Baughman R P, Lower E E. Leflunomide for chronic sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis. 2004;  21 43-48
• 54 Joseph A, Raj D, Dua H S et al.. Infliximab in the treatment of refractory posterior uveitis.  Ophthalmology. 2003;  110 1449-1453
• 55 Irani S K, Dobbins W O. Hepatic granulomas: a review of 73 patients from one hospital and survey of the literature.  J Clin Gastroenterol. 1979;  1 131-143
• 56 Vatti R, Sharma O P. Course of asymptomatic liver involvement in sarcoidosis: the role of therapy in selected cases.  Sarcoidosis Vasc Diffuse Lung Dis. 1997;  14 73-76
• 57 Lehmuskallio E, Hannuksela M, Halme H. The liver in sarcoidosis.  Acta Med Scand. 1977;  202 293-298
• 58 Hercules H D, Bethlem N M. Value of liver biopsy in sarcoidosis.  Arch Pathol Lab Med. 1984;  108 831-834
• 59 Chamuleau R A, Sprangers R L, Alberts C, Schipper M E. Sarcoidosis and chronic intrahepatic cholestasis.  Neth J Med. 1985;  28 470-476
• 60 Klatskin G. Hepatic granulomas: problems in interpretation.  Ann NY Acad Sci. 1976;  278 427-432
• 61 Devaney K, Goodman Z D, Epstein M S, Zimmerman H J, Ishak K G. Hepatic sarcoidosis: clinicopathologic features in 100 patients.  Am J Surg Pathol. 1993;  17 1272-1280
• 62 Judson M A. Hepatic and splenic sarcoidosis. In: Baughman RP Sarcoidosis: Lung Biology in Health and Disease. New York; Marcel Dekker 2006 210: 571-592
• 63 James D G, Sherlock S. Sarcoidosis of the liver.  Sarcoidosis. 1994;  11 2-6
• 64 Israel H L, Margolis M L, Rose L J. Hepatic granulomatosis and sarcoidosis.  Dig Dis Sci. 1984;  29 353-356
• 65 Maddrey W C, Johns C J, Boitnott J K, Iber F L. Sarcoidosis and chronic hepatic disease: a clinical and pathologic study of 20 patients.  Medicine. 1970;  49 375-395
• 66 Ishak K G. Sarcoidosis of the liver and bile ducts.  Mayo Clin Proc. 1998;  73 467-472
• 67 Warshauer D M, Dumbleton S A, Molina P L et al.. Abdominal CT findings in sarcoidosis: radiologic and clinical correlation.  Radiology. 1994;  192 93-98
• 68 Warshauer D M, Molina P L, Hamman S M et al.. Nodular sarcoidosis of the lever and spleen: analysis of 32 cases.  Radiology. 1995;  195 757-762
• 69 Britt A R, Francis I R, Glazer G M, Ellis J H. Sarcoidosis: abdominal manifestations at CT.  Radiology. 1991;  178 91-94
• 70 Folz S J, Johnson D, Swensen S J. Abdominal manifestations of sarcoidosis in CT studies.  J Comput Assist Tomogr. 1995;  19 573-579
• 71 Farman J, Ramirez G, Brunetti J et al.. Abdominal manifestations of sarcoidosis: CT appearances.  Clin Imaging. 1995;  19 30-33
• 72 Nakata K, Iwata K, Kojima K, Kanai K. Computed tomography of liver sarcoidosis.  J Comput Assist Tomogr. 1989;  13 707-708
• 73 Scott G C, Berman J M, Higgins J L. CT patterns of nodular hepatic and splenic sarcoidosis: a review of the literature.  J Assist Comput Tomogr. 1997;  21 369-372
• 74 Rudzki C, Ishak K G, Zimmerman H J. Chronic intrahepatic cholestasis of sarcoidosis.  Am J Med. 1975;  59 373-387
• 75 Bass N M, Burroughs A K, Scheuer P J, James D G, Sherlock S. Chronic intrahepatic cholestasis due to sarcoidosis.  Gut. 1982;  23 417-421
• 76 Pereira-Lima J, Schaffner F. Chronic cholestasis in hepatic sarcoidosis with clinical features resembling primary biliary cirrhosis: report of two cases.  Am J Med. 1987;  83 144-148
• 77 Thomas E, Micci D. Chronic intrahepatic cholestasis with granulomas and biliary cirrhosis.  JAMA. 1977;  238 337-338
• 78 Baughman R P. Sarcoidosis: usual and unusual manifestations.  Chest. 1988;  94 165-170
• 79 Bloom R, Sybert A, Mascetello V J. Granulomatous biliary tract obstruction due to sarcoidosis.  Am Rev Respir Dis. 1978;  117 783-787
• 80 Valla D, Pessegueiro-Miranda H, Degott C et al.. Hepatic sarcoidosis with portal hypertension: a report of seven cases with a review of the literature.  Q J Med. 1987;  63 531-544
• 81 Tekeste H, Latour F, Levitt R E. Portal hypertension complicating sarcoid liver disease: case report and review of the literature.  Am J Gastroenterol. 1984;  79 389-396
• 82 Vilinskas J, Joyeuse R, Serlin O. Hepatic sarcoidosis with portal hypertension.  Am J Surg. 1970;  120 393-396
• 83 Melissant C F, Smith S J, Kazzaz B A, Demedts M. Bleeding varices due to portal hypertension in sarcoidosis.  Chest. 1993;  103 628-629
• 84 Lu C L, Chen C Y, Hou M C, Chang F Y, Lee S D. The experience of endoscopic tissue glue injection in the treatment of hepatic sarcoidosis related gastric variceal bleeding: report of a case.  Hepatogastroenterology. 1999;  46 2293-2295
• 85 Russi E W, Bansky G, Pfaltz M et al.. Budd-Chiari Syndrome in sarcoidosis.  Am J Gastroenterol. 1986;  81 71-75
• 86 Nataline M R, Goyette R E, Owensby L C, Rubin R N. The Budd-Chiari syndrome in sarcoidosis.  JAMA. 1978;  239 2657-2658
• 87 Gottlieb J E, Israel H L, Steiner R M, Triolo J, Patrick H. Outcome in sarcoidosis: the relationship of relapse to corticosteroid therapy.  Chest. 1997;  111 623-631
• 88 Israel H L, Margolis M L, Rose L J. Hepatic granulomatosis and sarcoidosis.  Dig Dis Sci. 1984;  29 353-356
• 89 Israel H L, Goldstein R A. Hepatic granulomatosis and sarcoidosis.  Ann Intern Med. 1973;  79 669-678
• 90 Baughman R P. Methotrexate for sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis. 1998;  15 147-149
• 91 Murphy J R, Sjorgen M H, Kikendall J W, Peura D A, Goodman Z. Small duct abnormalities in sarcoidosis.  J Clin Gastroenterol. 1990;  12 555-561
• 92 Poupon R E, Chretien Y, Poupon R, Paumgartner G. Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy.  Hepatology. 1993;  17 599-603
• 93 Becheur H, Dall'osto H, Chatellier G et al.. Effect of ursodeoxycholic acid on chronic intrahepatic cholestasis due to sarcoidosis.  Dig Dis Sci. 1997;  42 789-791
• 94 Baratta L, Cascino A, Delfino M et al.. Ursodeoxycholic acid treatment in abdominal sarcoidosis.  Dig Dis Sci. 2000;  45 1559-1562
• 95 Sherlock S, Dooley J. Hepatic sarcoidosis. In: Diseases of the Liver and Biliary System. 10th ed. Oxford; Blackwell Science 1997: 163-173
• 96 James D G. Life-threatening situations in sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis. 1998;  15 134-139
• 97 Mullins P D, Youngs G R. Favorable prognosis following variceal haemorrhage complicating hepatic sarcoidosis.  Eur J Gastroenterol Hepatol. 1995;  7 185-186
• 98 Casavilla F A, Gordon R, Wright H I et al.. Clinical course after liver transplantation in patients with sarcoidosis.  Ann Intern Med. 1993;  118 865-866
• 99 Bain V G, Kneteman N, Brown N E. Sarcoidosis, liver transplantation, and cyclosporine [letter].  Ann Intern Med. 1993;  119 1148
• 100 Fidler H M, Hadziyannis S J, Dhillon A P, Sherlock S, Burroughs A K. Recurrent hepatic sarcoidosis following liver transplantation.  Transplant Proc. 1997;  29 2509-2510
• 101 Hunt J, Gordon F D, Jenkins R L, Lewis W D, Khettry U. Sarcoidosis with selective involvement of a second allograft: report of a case and review of the literature.  Mod Pathol. 1999;  12 325-328
• 102 Muller C, Briegel J, Haller M et al. Munich Lung Transplant Group. . Sarcoidosis recurrence following lung transplantation.  Transplantation. 1996;  61 1117-1119
• 103 Barbers R G. Role of transplantation (lung, liver, and heart) in sarcoidosis.  Clin Chest Med. 1997;  18 865-874
• 104 Huang C T, Heurich A E, Sutton A L, Lyons H A. Mortality in sarcoidosis: a changing pattern of the causes of death.  Eur J Respir Dis. 1981;  62 231-238
• 105 Schulte W, Kirstien D, Drent M, Costabel U. Cardiac involvement in sarcoidosis.  European Respiratory Journal Monograph. 2005;  10 130-149
• 106 Sharma O P, Maheshwari A, Thaker K. Myocardial sarcoidosis.  Chest. 1993;  103 253-288
• 107 Silverman K J, Hutchins G M, Bulkley B H. Cardiac sarcoid: a clinicopathological study of 84 unselected patients with systemic sarcoidosis.  Circulation. 1978;  58 1204-1211
• 108 Bagg S A, Gordon L L, Judson M A. Diagnostic yield of non invasive tests for cardiac sarcoidosis [abstract].  Proc Am Thorac Soc. 2005;  2 A864
• 109 Yazaki Y, Osobe M, Hiroe M et al.. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone.  Am J Cardiol. 2001;  88 1006-1010
• 110 Fasano R, Rimmerman C M, Jaber W A. Cardiac sarcoidosis: a cause of infiltrative cardiomyopathy.  Cleve Clin J Med. 2004;  71 483-488
• 111 Desai M Y, Fallert M A. Rapidly progressing congestive heart failure due to cardiac sarcoidosis involving papillary muscles: a case report and brief review of the literature.  Cardiol Rev. 2003;  11 163-168
• 112 Sekiguchi M, Yazaki Y, Isobe M, Hiroe M. Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations.  Cardiovasc Drugs Ther. 1996;  10 495-510
• 113 Chapelon-Abric C, de Zuttere D, DuHaut P et al.. Cardiac sarcoidosis: a retrospective study of 41 cases.  Medicine. 2004;  83 315-334
• 114 Haraki T, Ueda K, Shintani H et al.. Spontaneous development of left ventricular aneurysm in a patient with untreated sarcoidosis.  Circ J. 2002;  66 519-521
• 115 Kato Y, Morimoto S, Uemura A et al.. Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block.  Sarcoidosis Vasc Diffuse Lung Dis. 2003;  20 133-137
• 116 Larsen F, Pehrsson S K, Hammar N et al.. ECG-abnormalities in Japanese and Swedish patients with sarcoidosis: a comparison.  Sarcoidosis Vasc Diffuse Lung Dis. 2001;  18 284-288
• 117 Boglioli L R, Taff M L, Funke S, Mihalakis I. Sudden death due to sarcoid heart disease.  J Forensic Sci. 1998;  43 1072-1073
• 118 Uemura A, Morimoto S, Hiramitsu S et al.. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies.  Am Heart J. 1999;  138 299-302
• 119 Umetani K, Ishihara T, Sawanobori T et al.. Successfully treated complete atrioventricular block with corticosteroid in a patient with cardiac sarcoidosis: usefulness of Gallium-67 and thallium-201 scintigraphy.  Intern Med. 2000;  39 245-248
• 120 Chin B B, Civilek A C, Mudun A. Resting Tl-201 scintigraphy in the evaluation of myocardial sarcoidosis.  Clin Nucl Med. 1997;  22 475-478
• 121 Barneveld P C, van Leeuwen C, van Isselt J W. Scintigraphic demonstration of myocardial sarcoidosis: the added value of single photon emission computed tomography.  J Nucl Cardiol. 1997;  4 256-257
• 122 Nakazawa A, Ikeda K, Ito Y et al.. Usefulness of dual ⁶⁷Ga and ^99mTc-sestamibi single-photon-emission scanning in the diagnosis of cardiac sarcoidosis.  Chest. 2004;  126 1372-1376
• 123 Doherty M J, Kumar K, Nicholson A A, McGivern D V. Cardiac sarcoidosis: the value of magnetic resonance imagine in diagnosis and assessment of response to treatment.  Respir Med. 1998;  92 697-699
• 124 Shimada T, Shimada K, Sakane T et al.. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DPTA-enhanced magnetic resonance imaging.  Am J Med. 2001;  110 520-527
• 125 Vignaux O, Dhote R, Duboe D et al.. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis.  Chest. 2002;  122 1895-1901
• 126 Okumura W, Iwasaki T, Toyama T et al.. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.  J Nucl Med. 2004;  45 1989-1998
• 127 Hiraga H, Yuwai K, Hiroe M et al.. Guideline for the Diagnosis of Cardiac Sarcoidosis: Study Report on Diffuse Pulmonary Diseases [Japanese]. Tokyo; Ministry of Health and Welfare 1993: 23-24
• 128 Judson M A, Baughman R P, Teirstein A S, Terrin M L, Yeager Jr H. ACCESS Research Group . Defining organ involvement in sarcoidosis: the ACCESS proposed instrument.  Sarcoidosis Vasc Diffuse Lung Dis. 1999;  16 75-86
• 129 Roberts S D, Wilkes D S, Burgett R A, Knox K S. Refractory sarcoidosis responding to infliximab.  Chest. 2003;  124 2028-2031
• 130 Deng J C, Baughman R P, Lynch III J P. Cardiac involvement in sarcoidosis.  Semin Respir Crit Care Med. 2002;  23 513-527
• 131 Mezaki T, Chinushi M, Washizuka T et al.. Discrepancy between inducibility of ventricular tachycardia and activity of cardiac sarcoidosis: requirement of defibrillator implantation for the inactive stage of cardiac sarcoidosis.  Intern Med. 2001;  40 731-735
• 132 Smedema J P, Snoep G, van Kroonenburgh M PG et al.. Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands.  Chest. 2005;  128 30-35
• 133 Stern B J, Krimholz A, Johns C et al.. Sarcoidosis and its neurologic manifestations.  Arch Neurol. 1985;  42 909-917
• 134 James D G, Sharma O P. Neurosarcoidosis.  Proc R Soc Med. 1967;  60 1169-1170
• 135 Sharma O P, Sharma A M. Sarcoidosis of the nervous system: a clinical approach.  Arch Intern Med. 1991;  151 1317-1321
• 136 Hoitsma E, Sharma O P. Neurosarcoidosis.  European Respiratory Journal Monograph. 2005;  10 164-187
• 137 Kumar N, Frohmam E M. Spinal neurosarcoidosis mimicking an idiopathic inflammatory demyelinating syndrome.  Arch Neurol. 2004;  61 586-589
• 138 Zajieck J P, Scolding N J, Foster O et al.. Central nervous system sarcoidosis: diagnosis and management.  Q J Med. 1999;  92 103-117
• 139 Oksanen V. Neurosarcoidosis: clinical presentations and course in 50 patients.  Acta Neurol Scand. 1896;  73 283-290
• 140 Plotkin G R, Patel B R. Neurosarcoidosis presenting as chronic lymphocytic meningitis.  Pa Med. 1986;  89 36-37
• 141 Powers W J, Miller F M. Sarcoidosis mimicking glioma: case report and review of intercranial sarcoidosis like mass lesions.  Neurology. 1981;  31 907-910
• 142 Christoforidis G A, Spickler E M, Recio M V, Mehta B M. MR and CNS sarcoidosis: correlation of imaging features to clinical symptoms and response to treatment.  AJNR Am J Neuroradiol. 1999;  20 655-669
• 143 Dumas J L, Valeyre D, Chapelon-Abric C et al.. Central nervous system sarcoidosis: follow-up at MR imaging during steroid therapy.  Radiology. 2000;  214 411-420
• 144 Guoth M S, Kim J, de Lotbiniere A CJ, Brines M L. Neurosarcoidosis presenting as hypopituitarism and a cystic pituitary mass.  Am J Med Sci. 1998;  315 220-224
• 145 Konrad D, Gartenmann M, Martin E, Schoenle E J. Central diabetes insipidus as the first manifestation of neurosarcoidosis in a 10-year-old girl.  Horm Res. 2000;  54 98-100
• 146 Bullmann C, Faust M, Hoffmann A et al.. Five cases with central diabetes insipidus and hypogonadism as first presentation or neurosarcoidosis.  Eur J Endocrinol. 2000;  142 365-372
• 147 Fery F, Plat L, van de Borne P et al.. Impaired counterregulation of glucose in a patient with hypothalamic sarcoidosis.  N Engl J Med. 1999;  340 852-856
• 148 Sculley R E, Mark E J, McNeely W F et al.. Case records of the Massachusetts General Hospital, Case 8-1998.  N Engl J Med. 1998;  338 747-754
• 149 Hashmi M, Kyritsis A P. Diagnosis and treatment of intramedullary spinal cord sarcoidosis.  J Neurol. 1998;  245 178-185
• 150 Miller R, Sheron N, Semple S. Sarcoidosis presenting with acute Guillain-Barré syndrome.  Postgrad Med J. 1989;  65 765-767
• 151 Nemni R, Galassi G, Cohen M et al.. Symmetric sarcoid polyneuropathy: analysis of sural nerve biopsy.  Neurology. 1981;  31 1217-1223
• 152 Delaney P. Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases.  Ann Intern Med. 1977;  87 336-345
• 153 Bona J R, Facker S M, Fendley M J, Nemeroff C B. Neurosarcoidosis as a cause of refractory psychosis: a complicated case report.  Am J Psychiatry. 1998;  155 1106-1108
• 154 Hoitsma E, Marziniak M, Faber C G et al.. Small fiber neuropathy in sarcoidosis.  Lancet. 2002;  359 2085-2086
• 155 Hoitsma E, Drent M, Venstraete E et al.. Abnormal warm and cold sensation thresholds suggestive of small-fibre neuropathy in sarcoidosis.  Clin Neurophysiol. 2003;  114 2326-2333
• 156 Verbraecken J, Hoitsma E, van der Grinten C P et al.. Sleep disturbances associated with periodic leg movements in chronic sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis. 2004;  21 137-146
• 157 Israel H L, Albertine K H, Park C H, Patrick H. Whole-body gallium 67 scans: role in diagnosis of sarcoidosis.  Am Rev Respir Dis. 1991;  144 1182-1186
• 158 Sharma O P. Neurosarcoidosis: a personal perspective based on the study of 37 patients.  Chest. 1997;  112 220-228
• 159 Ferriby D, de Seze J, Stojkovic T et al.. Long-term follow-up of neurosarcoidosis.  Neurology. 2001;  57 927-929
• 160 Lower E E, Broderick J P, Brott T G, Baughman R P. Diagnosis and management of neurological sarcoidosis.  Arch Intern Med. 1997;  157 1864-1868
• 161 Sharma O P. Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurological involvement.  Arch Neurol. 1998;  55 1248-1254
• 162 Agbogu B N, Stern B J, Sewell C, Yang G. Therapeutic considerations in patients with refractory neurosarcoidosis.  Arch Neurol. 1995;  52 875-879
• 163 Doty J D, Mazur J E, Judson M A. Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen.  Chest. 2003;  124 2023-2026
• 164 Stern B J, Schonfeld S A, Sewell C et al.. The treatment of neurosarcoidosis with cyclosporine.  Arch Neurol. 1992;  49 1065-1072
• 165 Doty J D, Mazur J E, Judson M A. Treatment of sarcoidosis with infliximab.  Chest. 2005;  127 1064-1071
• 166 Kang S, Suh J H. Radiation therapy for neurosarcoidosis: report of three cases from a single institution.  Radiat Oncol Investig. 1999;  7 309-312
• 167 Sharma O P. Vitamin D, calcium, and sarcoidosis.  Chest. 1996;  109 535-539
• 168 Bell N H, Stern P H, Pantzer E et al.. Evidence that increased circulating 1-α,25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.  J Clin Invest. 1979;  64 218-225
• 169 Adams J S, Sharma O P, Gacad M A, Singer F R. Metabolism of 25-hydroxyvitamin D₃ by cultured pulmonary alveolar macrophages in sarcoidosis.  J Clin Invest. 1983;  72 1856-1860
• 170 Adams J S, Gacad M A. Characterization of 1α-hydroxylation of vitamin D₃ sterols by cultured alveolar macrophages from patients with sarcoidosis.  J Exp Med. 1985;  161 755-765
• 171 Sharma O P, Trowell J, Cohen N et al.. Abnormal calcium metabolism in sarcoidosis. In: Turiaf J, Chabot J La sarcoidose: Rapp IV Conf Intern. Paris; Maison de Cie 1967: 627-632
• 172 Rizzato G, Columbo P. Nephrocalcinosis as a presenting feature of chronic sarcoidosis: a prospective study.  Sarcoidosis Vasc Diffuse Lung Dis. 1996;  13 167-172
• 173 Sharma O P. Renal sarcoidosis and hypercalcemia.  European Respiratory Journal Monograph. 2005;  10 220-232
• 174 Adams J S, Diz M M, Sharma O P. Effective reduction in the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia with short-course of chloroquine therapy.  Ann Intern Med. 1989;  111 437-438
• 175 Barre P E, Gascon-Barre M, Meekins J L et al.. Hydroxychloroquine treatment of hypercalcemia in a patient with sarcoidosis undergoing hemodialysis.  Am J Med. 1987;  82 1259-1262
• 176 Conron M, Beynon H LC. Ketoconazole for the treatment of refractory hypercalcemic sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis. 2000;  17 277-280
• 177 Sharma O P. Sarcoidosis of the upper respiratory tract: selected cases emphasizing diagnostic and therapeutic difficulties.  Sarcoidosis Vasc Diffuse Lung Dis. 2002;  19 227-233
• 178 Milton C M. Sarcoidosis in ENT practice.  Clin Otolaryngol Allied Sci. 1976;  278 416
• 179 James D G, Barter S, Jash D et al.. Sarcoidosis of the upper respiratory tract (SURT).  J Laryngol Otol. 1982;  96 711-718
• 180 Bower J S, Belen J E, Weg J G, Dantzker D R. Manifestations and treatment of laryngeal sarcoidosis.  Am Rev Respir Dis. 1980;  122 325-332
• 181 Krespi Y P, Mitrani M, Hussain S, Meltzer C J. Treatment of laryngeal sarcoidosis with intralesional steroid injection.  Ann Otol Rhinol Laryngol. 1987;  96 713-715
• 182 Jakse R, Fleischmann G. Diagnosis and therapy of laryngeal sarcoidosis.  HNO. 1985;  33 118-123
• 183 Tobias J K, Santiago S M, Williams A J. Sarcoidosis as a cause of left recurrent laryngeal nerve palsy.  Arch Otolaryngol Head Neck Surg. 1990;  116 971-972
• 184 Sebastian B, Kleinsasser O. Sarcoidosis of the larynx.  Laryingol Rhinol Otol. 1985;  64 622-626
• 185 Lewis S J, Ainslie G M, Bateman E D. Efficacy of azathioprine as second-line treatment in pulmonary sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis. 1999;  16 87-92
• 186 Costabel U, Guzman J. Bronchoalveolar lavage in interstitial lung disease.  Curr Opin Pulm Med. 2001;  7 255-261
• 187 Baughman R P, Lower E E. Infliximab for refractory sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis. 2001;  18 70-74
• 188 Hammond B L, Kataria Y P. Nasal sarcoidosis with septal perforation.  J Otolaryngol. 1980;  9 31-34
• 189 Pila Perez R, Sanchex Baez A, Madriano Lopez L. Nasal sarcoidosis: report of the first case in Cuba.  Acta Otorrinolaringol Esp. 1990;  4 243-244
• 190 Jansen T LTA, Geusens P PMM. Sarcoidosis: joint, muscle, and bone involvement.  European Respiratory Journal Monograph. 2005;  10 210-219
• 191 West S G, Kotzin B L. Sarcoidosis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH Rheumatology. 3rd ed. Edinburgh; Mosby, Elsevier 2003: 1735-1752
• 192 Awada H, Abi-Karam G, Fayad F. Musculoskeletal and other extrapulmonary disorders in sarcoidosis.  Best Pract Res Clin Rheumatol. 2003;  17 971-987
• 193 Glennas A, Kvein T K, Melby K et al.. Acute sarcoid arthritis: occurrence, seasonal onset, clinical features, and outcome.  Br J Rheumatol. 1995;  34 45-50
• 194 Torralba K D, Quismorio F R. Sarcoid arthritis: a review of clinical features, pathology, and therapy.  Sarcoidosis Vasc Diffuse Lung Dis. 2003;  20 95-103
• 195 James D G, Neville E, Carsatairs L S. Bone and joint sarcoidosis.  Semin Arthritis Rheum. 1976;  6 53-81
• 196 Pettersson T. Rheumatic features of sarcoidosis.  Curr Opin Rheumatol. 1998;  10 73-78
• 197 Sokoloff L, Bunim J J. Clinical and pathological studies of joint involvement in sarcoidosis.  N Engl J Med. 1959;  260 841-847
• 198 Wilcox A, Bharadwaj P, Sharma O P. Bone sarcoidosis.  Curr Opin Rheumatol. 2000;  12 321-329
• 199 Kataria Y P, Whitcomb M E. Splenomegaly in sarcoidosis.  Arch Intern Med. 1980;  140 35-37
• 200 Salazar A, Mana J, Corbella X, Albareda J M, Pujol R. Splenomegaly in sarcoidosis: report of 16 cases.  Sarcoidosis. 1995;  12 131-134
• 201 Selroos O, Koivunen E. Usefulness of fine-needle aspiration biopsy of the spleen in diagnosis of sarcoidosis.  Chest. 1983;  83 193-195
• 202 Taavitsainen M, Koivuniemi A, Helmminen J et al.. Aspiration biopsy of the spleen in patients with sarcoidosis.  Acta Radiol. 1987;  28 723-725
• 203 Warshauer D M, Dumbleton S A, Molina P L et al.. Abdominal CT findings in sarcoidosis: radiologic and clinical correlation.  Radiology. 1994;  192 93-98
• 204 Folz S J, Johnson D, Swenson S J. Abdominal manifestations of sarcoidosis in CT studies.  J Comput Assist Tomogr. 1995;  19 573-579
• 205 Selroos O. Sarcoidosis of the spleen.  Acta Med Scand. 1976;  200 337-340
• 206 Thadani U, Aber C P, Taylor J J. Massive splenomegaly, pancytopenia and haemolytic anemia in sarcoidosis.  Acta Haematol. 1975;  53 230-240
• 207 Haran M Z, Feldberg E, Miller G, Berrebi A. Sarcoidosis presenting as massive splenomegaly and bicytopenia.  Am J Hematol. 2000;  63 232-233
• 208 Britt A R, Francis I R, Glazer G M, Ellis J H. Sarcoidosis: abdominal manifestations at CT.  Radiology. 1991;  178 91-94
• 209 Warshauer D M, Molina P L, Hamman S M et al.. Nodular sarcoidosis of the liver and spleen: analysis of 32 cases.  Radiology. 1995;  195 757-762
• 210 Ali Y, Popescu A, Woodlock T J. Extrapulmonary sarcoidosis: rapid spontaneous remission of marked splenomegaly.  J Natl Med Assoc. 1996;  88 714-716
• 211 Webb A K, Mitchell D N, Bradstreet C MP, Salsbury A J. Splenomegaly and splenectomy in sarcoidosis.  J Clin Pathol. 1979;  32 1050-1053
• 212 Coon W W. Splenectomy for splenomegaly and secondary hypersplenism.  World J Surg. 1985;  9 437-443
• 213 Rizzato G, Montemurro L. The clinical spectrum of the sarcoid peripheral lymph node.  Sarcoidosis Vasc Diffuse Lung Dis. 2000;  17 71-80
• 214 Pietinalho A, Ohmichi M, Hiraga Y et al.. The mode of presentation of sarcoidosis in Finland and Hikkaido, Japan: a comparative analysis of 571 Finnish and 686 Japanese patients.  Sarcoidosis Vasc Diffuse Lung Dis. 1996;  13 159-166
• 215 Lower E E, Smith J T, Martelo O J, Baughman R P. The anemia of sarcoidosis.  Sarcoidosis. 1988;  5 51-55
• 216 Baughman R P, Hurtubise P. Systemic immune response of patients with active pulmonary sarcoidosis.  Clin Exp Immunol. 1985;  61 535-541
• 217 Lower E E. Rare forms of sarcoidosis. In: Baughman RP Sarcoidosis: Lung Biology in Health and Disease. New York; Marcel Dekker 2006 210: 651-670
• 218 Spruit M A, Thomeer M J, Gosselink R et al.. Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status.  Thorax. 2005;  60 32-38
• 219 Silverstein A, Siltzbach L E. Muscle involvement in sarcoidosis.  Arch Neurol. 1969;  21 235-241
• 220 Kidd D, Benyon H LC. The neurological complications of systemic sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis. 2003;  20 85-94
• 221 Gansler T S, Wheeler J E. Mammary sarcoidosis: two cases and literature review.  Arch Pathol Lab Med. 1984;  108 673-675
• 222 Gisvold J J, Crotty T B, Johnson R E. Sarcoidosis presenting as speculated breast mass.  Mayo Clin Proc. 2000;  75 293-295
• 223 Hunsaker A R, Munden R F, Pugatch R D, Mentzer S J. Sarcoidlike reaction in patients with malignancy.  Radiology. 1996;  200 255-261
• 224 Kramar A, Droz J P, Rey A et al.. Prognostic factors in non-seminomatous germ cell tumours of the testis: experience at the Institute Gustave-Roussy.  Eur Urol. 1993;  23 188-195
• 225 Parveen A S, Elliott H, Howell R. Sarcoidosis of the ovary.  J Obstet Gynaecol. 2004;  24 465
• 226 Boakye K, Omalu B, Thomas L. Fallopian tube and pulmonary sarcoidosis: a case report.  J Reprod Med. 1997;  42 533-535
• 227 DiCarlo Jr F J, DiCarlo J P, Robboy S J, Lyons M M. Sarcoidosis of the uterus.  South Med J. 2002;  95 884-888
• 228 Klein P A, Appel J, Callen J P. Sarcoidosis of the vulva: a rare cutaneous manifestation.  J Am Acad Dermatol. 1998;  39 281-283
• 229 Uthman I W, Bizri A R, Shabb N S et al.. Peritoneal sarcoidosis: case report and review of the literature.  Semin Arthritis Rheum. 1999;  28 351-354
• 230 Bernaciak J, Spina J C, Curros M L et al.. Case report: peritoneal sarcoidosis in an unusual location.  Semin Respir Crit Care Med. 2002;  23 597-600
• 231 Lemerre D, Caron F, Delval O et al.. Thyroid manifestations of sarcoidosis: a case report.  Rev Pneumol Clin. 1999;  53 393-396
• 232 Nakamura H, Genma R, Mikami T et al.. High incidence of positive autoantibodies against thyroid peroxidase and thyroglobulin in patients with sarcoidosis.  Clin Endocrinol (Oxf). 1997;  46 467-472
• 233 Sartin J S, Walker R C. Granulomatous hepatitis: a retrospective review of 88 cases at the Mayo Clinic.  Mayo Clin Proc. 1991;  66 914-918
• 234 Merrill P T, Kim J, Cox T A et al.. Uveitis in the southeastern United States.  Curr Eye Res. 1997;  16 865-874